Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
6th grade Avg
|
New words:
administered, aforementioned, antigen, August, beta, contingent, discontinued, Dondero, dosing, Duke, earlier, efficacy, formally, formulated, Immunex, intranasal, intranasally, January, jointly, losscarryforward, mice, milestone, mutant, option, patent, pledge, pneumoniae, pr, promissory, recurring, reduced, return, Richard, royalty, safety, significantly, Sponsored, study, subsequent, subsequently, toxoid, transition, University
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.24 Sponsored Research Agreement
- 10.24 Amendment #1 to Sponsored Research Agreement
- 10.24 Amendment #2 Sponsored Research Agreement
- 10.24 Amendment #3 to Sponsored Research Agreement
- 10.25 License Agreement
- 10.26 Loand and Pledge Agreement
- 10.27 Non-recourse Secured Promissory Note
- 27 Loand and Pledge Agreement
Cistron Biotechnology similar filings
External links